ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 166

Prevalence of Radiographic Thymic Alteration and Its Clinical Association in Systemic Autoimmune Diseases

Okinori Murata1, Katsuya Suzuki1, Hiroaki Sugiura2, Yasushi Kondo1, Hidekata Yasuoka1, Kunihiro Yamaoka1 and Tsutomu Takeuchi1, 1Keio University School of Medcine, Division of Rheumatology, Department of Internal Medicine, Tokyo, Japan, 2Keio University School of Medcine, Division of Diagnostic Radiology, Department of Radiology, Tokyo, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: autoantibodies, Computed tomography (CT), pathogenesis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  While thymic alteration such as hyperplasia, cyst and neoplasia has been precisely studied particularly in myasthenia gravis [1], only a few small-scale studies have been reported in a part of systemic autoimmune diseases [2-4]. We conducted a large-scale cross-sectional analysis on prevalence of radiographic thymic alteration and its clinical association in various systemic autoimmune diseases.

Methods:  Consecutive and unbiased 500 patients who had visited at our service and had been evaluated by chest CT scan between January 2013 and December 2015 were enrolled. Thymus size and the radiographic pattern on high-resolution CT image were quantitatively interpreted. We defined hyperplasia as more than 13mm thickness and graded the patterns by four-point scale (grade 0-3) according to previous study [5,6]. Their association to clinical information was statistically analyzed.

Results:  Thymoma and thymic cyst were found in 3 (0.6%) and 1 (0.2%), respectively. After above cases and less than 30 year-old patients were excluded, 488 were served for following analysis. 78% were women and mean age was 63.0 ± 13.9 years old. These included 168 patients with rheumatoid arthritis (RA), 63 with systemic sclerosis (SSc), and 37 with primary Sjögren’s syndrome (pSS). Thymic hyperplasia was found in 90 (18%) overall. These included 41 (24%) with RA, 6 (10%) with SSc, and 7 (19%) with pSS. Remarkably, patients with granulated pattern (grade 1 and over) was more frequent (42%) as compared to undiagnosed controls. These included 78 (46%) patients for RA, 32 (51%) patients for SSc, and 17 (46%) for pSS. Regarding clinical association, when RA patients is classified by hyperplasia and granulated pattern, proportion of serum anti-cyclic citrullinated peptide antibody (ACPA)-positivity were significantly higher in alteration group compared to normal group (93% vs. 70% and 89% vs. 63%; P=0.004 and 0.0005, odds ratio=6.1 and 5.0). In addition, titer of ACPA was also positively correlated to both hyperplasia and granulated pattern (P=0.048 and 0.009).

Conclusion:  Thymic alteration was found in quite a few patients with various systemic autoimmune diseases. In RA patients, radiographic thymic alteration, especially granulated pattern significantly correlates to ACPA status and may reflect activation of germinal centers in the thymic medulla. References: [1] Clinic Rev Allerg Immunol 2016 Jun 6. [Epub ahead of print], [2] Semin Arthritis Rheum. 1998; 28:73-79, [3] Joint Bone Spine. 2013; 80:48-51, [4] Rheumatology(Oxford). 2014; 53:732-736, [5] Radiology. 2013; 268(1):245-253, [6] Eur Radiol. 2016; 26(1):15-24


Disclosure: O. Murata, None; K. Suzuki, None; H. Sugiura, None; Y. Kondo, None; H. Yasuoka, None; K. Yamaoka, None; T. Takeuchi, None.

To cite this abstract in AMA style:

Murata O, Suzuki K, Sugiura H, Kondo Y, Yasuoka H, Yamaoka K, Takeuchi T. Prevalence of Radiographic Thymic Alteration and Its Clinical Association in Systemic Autoimmune Diseases [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-radiographic-thymic-alteration-and-its-clinical-association-in-systemic-autoimmune-diseases/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-radiographic-thymic-alteration-and-its-clinical-association-in-systemic-autoimmune-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology